TNX-102 SL Tablet
TNX-CY-F111
Phase 1 small_molecule active
Quick answer
TNX-102 SL Tablet for Pharmakokinetic is a Phase 1 program (small_molecule) at Tonix Pharmaceuticals Holding with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Tonix Pharmaceuticals Holding
- Indication
- Pharmakokinetic
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active